Request a Proposal  

Pharm-Olam Blog

News

Pharm-Olam is singularly committed to optimizing every aspect of a clinical trial across all functional areas. We have enrolled thousands of patients in planned studies and have been frequently enlisted for rescue studies, assistance with data protection and US federal funding for clinical research.

John W Colby III

John is the head of marketing at Pharm-Olam, and has had the opportunity to see the industry from different perspectives over his 15 years; from proposals to sales, to operations and partnership oversight, to corporate strategy and marketing. When not on the job, you will probably find John out on the hiking trails with his wife and four young boys, enjoying the great outdoors.

Blog Feature

By: John W Colby III
July 31st, 2018

Houston, July 31, 2018 – Pharm-Olam International, a global, full-service contract research organization (CRO) specializing in oncology, infectious diseases and vaccines, rare and orphan diseases, provides multiple resources for life science organizations to comply with the new European Union General Data Protection Regulation (GDPR). Pharm-Olam provides education and consultation on how the GDPR affects clinical trial conduct and also works directly with companies to achieve compliance.